Allgemein, Press 27 Apr 2021 New Protein from BioTeZ: Recombinant SARS-CoV-2 Nucleocapsid Protein full length, His-tagged ahnert
Allgemein 14 May 2020 Independent studies show increased thrombosis and pulmonary embolism in COVID-19 patients Research teams at Hamburg-Eppendorf University Hospital and Beijing Union Medical College Hospital Beijing found that SARS-CoV-2 infections can lead to thrombosis and pulmonary embolism. In addition to atypical pneumonia, which… ahnert
Allgemein 30 Apr 2020 BioTeZ increased the production capacities of Real-time qPCR probes for COVID-19 research and diagnostics The recent emergence of the coronavirus SARS-CoV-2 (the virus that causes COVID-19) has led to a need for higher quantities for rapid and reliable detection. BioTeZ react on the increased… ahnert
Allgemein 04 Jun 2019 BioTeZ established a novel surface functionalization kit -the TA-PAS system The strong interaction between streptavidin and biotin is widely utilized in biotechnological applications (1). The new TAPAS label was developed to extend the portfolio for assay manufactured and will be… ahnert
Allgemein 04 Jun 2019 New method for directly measuring the primary effect of drugs BioTeZ is starting to develop a new method for directly measuring the primary effect of drugs on their target molecule. BioTeZ starts the project for the development of a companion… ahnert
